Vivos Therapeutics, Inc. Other Current Liabilities
Vivos Therapeutics, Inc. (VVOS) had Other Current Liabilities of $1.20 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Current $1.20M.
- 2026-03-31: Other Liabilities, Current $1.23M.
- 2025-12-31: Other Liabilities, Current $850.00K.
- 2025-09-30: Other Liabilities, Current $987.00K.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-06-30 | $1.20M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.23M 10-Q · filed 2026-05-20 |
| 2025-12-31 | $850.00K 10-Q · filed 2026-08-14 |
| 2025-09-30 | $987.00K 10-Q · filed 2025-11-19 |
| 2025-06-30 | $1.01M 10-Q · filed 2025-08-19 |
| 2025-03-31 | $672.00K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $273.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $199.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $151.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $224.00K 10-Q · filed 2024-05-14 |
| 2023-12-31 | $198.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | $284.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $160.00K 10-Q · filed 2023-08-16 |
| 2023-03-31 | $127.00K 10-Q · filed 2023-06-08 |
| 2022-12-31 | $145.00K 10-K/A · filed 2024-07-30 |
| 2022-09-30 | $294.00K 10-Q · filed 2022-12-20 |
| 2022-06-30 | $361.00K 10-Q · filed 2022-12-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |